JPWO2023162456A1 - - Google Patents

Info

Publication number
JPWO2023162456A1
JPWO2023162456A1 JP2023528145A JP2023528145A JPWO2023162456A1 JP WO2023162456 A1 JPWO2023162456 A1 JP WO2023162456A1 JP 2023528145 A JP2023528145 A JP 2023528145A JP 2023528145 A JP2023528145 A JP 2023528145A JP WO2023162456 A1 JPWO2023162456 A1 JP WO2023162456A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023528145A
Other languages
Japanese (ja)
Other versions
JPWO2023162456A5 (https=
JP7339471B1 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023162456A1 publication Critical patent/JPWO2023162456A1/ja
Application granted granted Critical
Publication of JP7339471B1 publication Critical patent/JP7339471B1/ja
Publication of JPWO2023162456A5 publication Critical patent/JPWO2023162456A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2023528145A 2022-02-25 2022-12-26 癌転移抑制用のvipr2アンタゴニストペプチド Active JP7339471B1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022027791 2022-02-25
JP2022027791 2022-02-25
PCT/JP2022/047969 WO2023162456A1 (ja) 2022-02-25 2022-12-26 癌転移抑制用のvipr2アンタゴニストペプチド

Publications (3)

Publication Number Publication Date
JPWO2023162456A1 true JPWO2023162456A1 (https=) 2023-08-31
JP7339471B1 JP7339471B1 (ja) 2023-09-05
JPWO2023162456A5 JPWO2023162456A5 (https=) 2024-01-30

Family

ID=87765588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023528145A Active JP7339471B1 (ja) 2022-02-25 2022-12-26 癌転移抑制用のvipr2アンタゴニストペプチド

Country Status (5)

Country Link
US (1) US20250186540A1 (https=)
EP (1) EP4473973A4 (https=)
JP (1) JP7339471B1 (https=)
CN (1) CN118742316A (https=)
WO (1) WO2023162456A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4137502A4 (en) * 2020-03-30 2024-02-28 Ichimaru Pharcos Co., Ltd. Vipr2 antagonist peptide

Also Published As

Publication number Publication date
CN118742316A (zh) 2024-10-01
EP4473973A4 (en) 2026-01-21
WO2023162456A1 (ja) 2023-08-31
EP4473973A1 (en) 2024-12-11
US20250186540A1 (en) 2025-06-12
JP7339471B1 (ja) 2023-09-05

Similar Documents

Publication Publication Date Title
CL2025003608A1 (es) Sistema de transferencia de calor adaptable para caja de volcado y pared frontal
CA3246145A1 (https=)
BR102023012440A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
JPWO2023162456A1 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13164U (https=)
CN307045528S (https=)
BY23963C1 (https=)
CN307044871S (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)
BY13168U (https=)
CN307045165S (https=)
BY13166U (https=)
BY13165U (https=)
BY13157U (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230510

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230510

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20230510

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230510

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230519

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20230511

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230613

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230801

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230809

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230822

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230824

R150 Certificate of patent or registration of utility model

Ref document number: 7339471

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D03

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250